Open AccessPenile rehabilitation with low‐intensity extracorporeal shock wave therapy in patients after prostate cancer surgery. Early physiological changes and postoperative follow‐up outcomes
Author(s) -
Karakose Ayhan,
Yitgin Yasin
Publication year - 2021
Publication title -
international journal of clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 98
eISSN - 1742-1241
pISSN - 1368-5031
DOI - 10.1111/ijcp.14804
Subject(s) - medicine , tadalafil , erectile dysfunction , prostate cancer , extracorporeal shockwave therapy , urology , prostatectomy , extracorporeal shock wave therapy , surgery , urinary incontinence , cancer
To investigate the efficacy, safety and postoperative outcomes of using tadalafil and low‐intensity extracorporeal shock wave therapy (Li‐ESWT) on penile rehabilitation and preventing urinary incontinence after radical prostatectomy. Methods In total, we included 66 patients who used only tadalafil (n = 32) in group 1 and used tadalafil and treated by Li‐ESWT (n = 34) in group 2. We noted International Index of Erectile Function (IIEF) 5, daily incontinence pad measurements at preoperative, postoperative 3rd, 6th and 12th months respectively. We also evaluated penis blood flow and neovascularisation by penile doppler ultrasonography at postoperative 3rd and 12th months for all patients. Statistical analyses were performed with SPSS version 18. A P ‐value < .05 was considered significant. Results Preoperative demographic characteristics were similar in the two groups. There was a statistically significant improvement in IIEF‐5, which started at the 6th month and continued increasingly at the 12th month in group 2 compared with group 1. Also, there was a significant decrease in incontinence rate in group 2 compared with group 1 in the sixth month. Conclusions Combined use of tadalafil and Li‐ESWT is highly effective and safe for the treatment of erectile dysfunction and for the prevention of urinary incontinence after prostate cancer surgery.